Citywire printed articles sponsored by:
View the rest of this gallery online at http://citywire.co.uk/wealth-manager/gallery/a695113
The Expert View: Diageo, Centrica and British American Tobacco
by Harry Brooks on Aug 01, 2013 at 00:01
A roundup of some of the best analyst commentary on shares, also including Taylor Wimpey and Capita.
Our daily round-up of analyst recommendations and commentary, featuring Diageo, Centrica, British American Tobacco, Taylor Wimpey and Capita.
If you'd like to receive news alerts on any of the stocks mentioned in The Expert View, click on the star icons below to add them to your favourites. To buy shares via JP Morgan, click on the shopping trolley icon.
Canaccord downgrades Diageo despite strong growth
Canaccord has downgraded Diageo (DGE.L) from 'buy' to 'hold' despite yesterday's strong trading figures, saying it's all in the price already.
Net sales over the year rose 6% to £11.4 billion, at the top end of analysts' expectations, boosted by an acquisitions-fuelled 11% rise in sales in emerging markets.
'F13 results are solid on virtually all metrics,' Canaccord analyst Eddy Hargreaves said.
'However, the positives are already reflected in consensus (operating profit expected to grow +8% organically in F14, continuing the F13 trend) and in the share price; therefore with 2% downside to our unchanged target price we lower our rating to HOLD from Buy.'
Shares in the group closed at £20.54 on Wednesday, up 64.5p or 3.2%.
Centrica basks in shareholders' appreciation
Liberum Capital has reiterated its 'buy' recommendation Centrica (CNA.L) after the British Gas owner reported a 2% rise in first-half earnings.
Adjusted operating profits of £1.58 billion over the past six months beat consensus estimates of £1.5 billion, helped along by strong residential sales from British Gas.
The positive update followed Tuesday's news that Centrica is to buy US oil group Hess for more than £657 million.
Liberum's analysts said the conference call after the results suggested the management are confident of meeting 2013 market expectations and delivering real dividend growth.
Shares in the group closed at 391p on Wednesday, up 5.2p or 1.4%.
'Buy' British American Tobacco, Investec says
Investec has reiterated its 'buy' recommendation on British American Tobacco (BATS.L), saying things are looking up for the second half of the year.
Yesterday's first-half figures showed earnings per share 1% ahead of consensus expectations at 109.1p, but organic sales growth missed the Investec forecast by 2%.
'The underlying metrics look to be below expectations and testify to continuing challenges for both BAT and the industry,' analyst Martin Deboo said.
'However there are positive signs for H2: the rate of decline in Europe reduced in Q2 and BAT will lap the anniversary of tax changes in Brazil.' Consumer demand fluctuations and excise taxes and regulation are the major risks for the shares, Deboo added.
The analyst has a target price of £37.50 for the shares.
Shares in the group closed at £35.06 on Wednesday, up 43.5p or 1.3%.
Jefferies lifts target price on Taylor Wimpey
Jefferies has increased its target price for homebuilder Taylor Wimpey (TW.L) on the back of a strong first-half update.
The group operating margin rose to 13.1%, up from 11% in the year-ago period, and the operating profit was up 33.5% at £132.4 million.
'We are upgrading our FY14 and FY15 estimates by 2% following today's H1 results, reflecting higher operating margin assumptions in what we view as a recovering UK housing market,' analyst Anthony Codling said.
'Although the housing market has changed gear Taylor Wimpey's strategy has not, it remains focused on optimising shareholder value ahead of growing volumes. We increase our target price to 122p (+11p) and re-iterate our BUY rating on the shares.'
Shares in the group closed at 106.5p on Wednesday, up 0.3p or 0.3%.
Capita has a mountain to climb, Westhouse warns
Outsourcing giant Capita (CPI.L) is running out of wiggle room, according to Westhouse, meaning any slippage in sales over the rest of the year is likely to unsettle investors.
Last week's interims showed earnings exactly in line with Westhouse's £227 million target, but organic revenue growth of just 3% was well below what they'd pencilled in.
'Capita needs to deliver 13% organic to hit its 8%+ organic guidance for the full year,' the analysts noted, reiterating their 'sell' recommendation. 'This is all down to start dates of recent wins, which we think are mainly pinned down, but the point is there is hardly any room for slippage now, and any slippage that resulted in a scaling back of organic growth would be poorly received by the market.'
The valuation of the shares is currently at a five-year high of 13.2x enterprise value to earnings, Westhouse said. 'We believe that the current level of valuation requires a significant and sustained return to historical levels of organic growth that we believe will prove very challenging to deliver.'
Shares in the group closed at £10.43 on Wednesday, up 5p or 0.5%.